Advertisement
The superbug fungus – Candida auris is a deadly form of yeast that causes severe infections and illness in patients by entering the bloodstream.
“This yeast often does not respond to commonly used antifungal drugs, making infections difficult to treat,” says the CDC (Centers for Disease Control and Prevention).
Diagnosis and Risk
The fungal infection is diagnosed through blood culture or other body fluids. However, it is not clear enough for a confirmed diagnosis and thereby seeks special laboratory tests for Candida auris.
Diseases like diabetes, recent surgery, a broad-spectrum antibiotic, and antifungal use add to the risk of a fungal infection. It affects patients of all age groups, including the elderly and preterm infants.
Cases on Rise
The nursing home in Washington DC had recorded about 101 Candida auris cases that included 3 patients who were resistant to all three classes of antifungal medications. Moreover the Dallas area hospital recorded 22 infected individuals showing similar resistance to drugs.
Three out of five patients who were fully resistant to treatment had died both in Texas and one based in Washington.
READ RELATED: What is the current R rate in my area? How to track it every day
“This is really the first time we’ve started seeing clustering of resistance” in which patients seemed to be getting the infections from each other, says CDC’s, Meghan Lyman.
Treatment Options for the Deadly Infection
Although most cases show good response to a class of antifungal drugs known as echinocandins, certain group shows resistant to all three main classes of antifungal medications.
Hence this adds to the difficulty of treating these cases. The rate of death due to Candida auris infections has been reported to be 30-60% by the CDC. With this evidence, the US health agency has termed the emerging fungus as a serious global health threat.
Source: Medindia
Advertisement
Source:
